Patents by Inventor Roberto Tonelli

Roberto Tonelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apparatus for detecting and monitoring nasal pressure
    Publication number: 20240173506
    Abstract: An apparatus (10) for detecting and monitoring nasal pressure is described comprising: a nasal probe (15) adapted to be permanently placed inside a patient's nostril, wherein the nasal probe (15) comprises: a support ring (20) which defines inside it a through opening (25) and provided with an external surface (22) adapted to come into contact with the patient's nostril, a housing seat (30) defined within the external surface (22) of the support ring (20) for housing the end of a cannula (75) adapted to be connected to a pressure transducer (100), and an inflatable membrane (35) associated with the support ring (20) and configured to be selectively moved between: a first configuration, in which it is inflated and completely occludes the through opening (25), and a second configuration, in which it is deflated and leaves at least partially open the through opening (25).
    Type: Application
    Filed: March 23, 2023
    Publication date: May 30, 2024
    Inventors: Riccardo FANTINI, Roberto TONELLI, Ivana CASTANIERE, Enrico CLINI, Luca TABBI’, Alessandro MARCHIONI
  • Oligonucleotides for modulating gene expression and uses thereof
    Patent number: 10752900
    Abstract: The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoural or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: August 25, 2020
    Assignee: BIOGENERA S.P.A.
    Inventors: Roberto Tonelli, Leonardo Venturelli, Andrea Tortori, Luca Montemurro
  • OLIGONUCLEOTIDES FOR MODULATING GENE EXPRESSION AND USES THEREOF
    Publication number: 20180282731
    Abstract: The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoural or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.
    Type: Application
    Filed: June 15, 2018
    Publication date: October 4, 2018
    Applicant: BIOGENERA S.P.A.
    Inventors: Roberto Tonelli, Leonardo Venturelli, Andrea Tortori, Luca Montemurro
  • Oligonucleotides for modulating gene expression and uses thereof
    Patent number: 10023867
    Abstract: The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoral or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: July 17, 2018
    Assignee: BIOGENERA S.P.A.
    Inventors: Roberto Tonelli, Leonardo Venturelli, Andrea Tortori, Luca Montemurro
  • OLIGONUCLEOTIDES FOR MODULATING GENE EXPRESSION AND USES THEREOF
    Publication number: 20160040166
    Abstract: The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoural or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.
    Type: Application
    Filed: February 21, 2013
    Publication date: February 11, 2016
    Inventors: Roberto Tonelli, Leonardo Venturelli, Andrea Tortori, Luca Montemurro
  • Method for selective inhibition of human N-myc gene in N-myc expressing tumors through antisense and antigen peptido-nucleic acids (PNA)
    Patent number: 7947657
    Abstract: The present invention refers to sense and antisense peptide nucleic acids (PNAs). The present invention further refers to the use of said PNAs for preparing drugs for treating genetic diseases.
    Type: Grant
    Filed: April 29, 2004
    Date of Patent: May 24, 2011
    Assignees: Universita Degli Studi Di Parma, Universita Degli Studi Di Bolonga
    Inventors: Roberto Tonelli, Andrea Pession, Raffaele Fronza, Rosangela Marchelli, Roberto Corradini, Stefano Sforza
  • Method for selective inhibition of human n-myc gene in n-myc expressing tumors through antisense and antigen peptido-nucleic acids (pna)
    Publication number: 20070020632
    Abstract: The present invention refers to sense and antisense peptido-nucleic acids (PNAs). The present invention further refers to the use of said PNAs for preparing drugs for treating genetic diseases.
    Type: Application
    Filed: April 29, 2004
    Publication date: January 25, 2007
    Inventors: Roberto Tonelli, Andrea Pession, Raffaele Fronza, Rosangela Marchelli, Roberto Corradini, Stefano Sforza